CO4780018A1 - Composiciones farmaceuticas atomizadoras nasales que con- tienen un esteroide y un antihistaminico - Google Patents

Composiciones farmaceuticas atomizadoras nasales que con- tienen un esteroide y un antihistaminico

Info

Publication number
CO4780018A1
CO4780018A1 CO96065607A CO96065607A CO4780018A1 CO 4780018 A1 CO4780018 A1 CO 4780018A1 CO 96065607 A CO96065607 A CO 96065607A CO 96065607 A CO96065607 A CO 96065607A CO 4780018 A1 CO4780018 A1 CO 4780018A1
Authority
CO
Colombia
Prior art keywords
antihistamine
safe
effective amount
steroid
atomizing
Prior art date
Application number
CO96065607A
Other languages
English (en)
Inventor
Ronald Dean Cramer
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of CO4780018A1 publication Critical patent/CO4780018A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con una composición farmacéutica que contiene:a) Una cantidad segura y efectiva de un glucocorticoide seleccionado del grupo consistente de beclometasona, flunisolida, triamcinolona, fluticasona, mometasona, budesonida, sales farmacéuticamente aceptables de ellas y mezclas de ellas;b) Una cantidad segura y efectiva de un antihistamínico inhibidor de leucotrieno seleccionado del grupo consistente de cetirizina, loratadina, azelastina, sales de ellas farmacéuticamente aceptables, racematos ópticamente activos de ellas y mezclas de ellas; yc) Un portador intranasal.También se relaciona con un método para tratar los síntomas asociados con rinoconjuntivitis alérgica estacional o rinoconjuntivitis alérgica continua utilizando una cantidad segura y efectiva de dicha composición farmacéutica.
CO96065607A 1995-12-19 1996-12-13 Composiciones farmaceuticas atomizadoras nasales que con- tienen un esteroide y un antihistaminico CO4780018A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57479195A 1995-12-19 1995-12-19

Publications (1)

Publication Number Publication Date
CO4780018A1 true CO4780018A1 (es) 1999-05-26

Family

ID=24297657

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96065607A CO4780018A1 (es) 1995-12-19 1996-12-13 Composiciones farmaceuticas atomizadoras nasales que con- tienen un esteroide y un antihistaminico

Country Status (4)

Country Link
EP (1) EP0780127A1 (es)
AR (1) AR005138A1 (es)
CO (1) CO4780018A1 (es)
PE (1) PE34998A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849263A (en) * 1993-03-30 1998-12-15 Charlotte-Mecklenburg Hospital Authority Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
US7211582B1 (en) 1994-12-30 2007-05-01 Sepracor Inc. Methods for treating urticaria using descarboethoxyloratadine
EP0954318A1 (en) * 1996-06-04 1999-11-10 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
SE9604486D0 (sv) * 1996-12-05 1996-12-05 Astra Ab Novel formulation
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
AU6878098A (en) * 1997-04-30 1998-11-24 Warner-Lambert Company Topical nasal antiinflammatory compositions
EP1041990B1 (en) * 1997-12-23 2006-06-28 Schering Corporation Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
GB9806937D0 (en) 1998-03-31 1998-05-27 Procter & Gamble A spray device
US6248308B1 (en) 1998-04-14 2001-06-19 Sepracor Inc. Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma
AU2003204684B2 (en) * 1998-04-14 2005-11-24 Sepracor, Inc. Methods and compositions using cetrizine in compostion with leukotriene inhibitors for treating conditions responsive to leukotriene inhibition
US6384038B1 (en) 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
AR022378A1 (es) * 1998-09-10 2002-09-04 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
EP1020233A1 (en) 1999-01-13 2000-07-19 The Procter & Gamble Company Dosing and delivering system
AU3065299A (en) * 1999-03-01 2000-09-21 Schering Corporation Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids
GB9918559D0 (en) * 1999-08-07 1999-10-06 Glaxo Wellcome Kk Novel pharmaceutical formulation
JP2003511417A (ja) * 1999-10-08 2003-03-25 シェーリング コーポレイション 局所的鼻疾患治療
DE10064950A1 (de) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
SI1446119T1 (sl) 2001-09-18 2006-08-31 Nycomed Danmark Aps Sestavki, ki obsegajo ipratorij in ksilometazolin, za zdravljenje obicajnega prehlada
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CN1674916A (zh) 2002-08-30 2005-09-28 奥坦纳医药公司 环缩松与抗组胺药的组合用于治疗变应性鼻炎的用途
US7815924B2 (en) 2002-09-20 2010-10-19 Fmc Corporation Cosmetic composition containing microcrystalline cellulose
WO2004082589A2 (en) * 2003-03-20 2004-09-30 Ranbaxy Laboratories Limited Nasally administrable, bioavailable pharmaceutical composition of loratadine
US20050192261A1 (en) * 2003-09-15 2005-09-01 Jost-Price Edward R. Methods and reagents for the treatment of immunoinflammatory disorders
DK2522365T3 (en) * 2004-11-24 2017-02-06 Meda Pharmaceuticals Inc Compositions comprising azelastine and methods for its use
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
BRPI0609700A2 (pt) 2005-03-23 2010-04-20 Elan Pharma Int Ltd formulações de corticosteróide nanoparticulado e antihistamina
WO2008070264A2 (en) * 2006-10-10 2008-06-12 Case Western Reserve University Nasal spray composition and method for treating rhinitis, sinusitis or both
WO2011141929A2 (en) 2010-05-11 2011-11-17 Cadila Healthcare Limited Aqueous pharmaceutical compositions of fluticasone and olopatadine
RU2543326C2 (ru) * 2012-08-21 2015-02-27 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения зуда кожи
US9962397B2 (en) 2014-04-16 2018-05-08 John T. Given Intranasal medication delivery device and method of use thereof
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
CN107929738A (zh) * 2017-11-28 2018-04-20 贵州云峰药业有限公司 一种含盐酸氮卓斯汀的组合物
WO2022098319A1 (en) * 2020-11-09 2022-05-12 Pharmactive Ilac Sanayi Ve Ticarey A.S. Pharmaceutical compositions comprising azelastine, beclomethasone and relevant excipients

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136163A (en) 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
GB1421743A (en) 1972-04-18 1976-01-21 Wilkinson Sword Ltd Ingestible topical and other compositions
ZA821577B (en) 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
JPS5888334A (ja) 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル
US4767612A (en) 1987-01-23 1988-08-30 Rorer Pharmaceutical Corporation Triamcinolone acetonide for the treatment of allergic rhinitis
US4873259A (en) 1987-06-10 1989-10-10 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
EP0318093A3 (en) 1987-11-25 1990-12-05 Merck Frosst Canada Inc. Diarylquinoline diacids and their use as medicaments
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use

Also Published As

Publication number Publication date
AR005138A1 (es) 1999-04-14
EP0780127A1 (en) 1997-06-25
PE34998A1 (es) 1998-07-24

Similar Documents

Publication Publication Date Title
CO4780018A1 (es) Composiciones farmaceuticas atomizadoras nasales que con- tienen un esteroide y un antihistaminico
HUP0202862A2 (hu) A loteprednol és antihisztaminok új kombinációját tartalmazó gyógyszerkészítmény
HUP0000487A2 (hu) Neurokinin antagonistaként alkalmazható szubsztituált oximszármazékok
CO5170495A1 (es) Composiciones farmaceuticas para prevencion y tratamiento de enfermedades amiloidogenicas
RU2006132043A (ru) Комбинация и фармацевтический препарат для лечения ринита
HUP0202311A2 (hu) Aeroszollá alakított fertőzésgátló, gyulladásgátló és vértolulást gátló szerek az orrmelléküreg-gyulladás kezelésében
DE69943415D1 (de) Sarsasapogenin und Smilagenin zur Behandlung kognitiver Störungen
DE69231994T2 (de) Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
AR081393A2 (es) Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
MXPA02008064A (es) Combinacion novedosa de antihistaminas no sedantes que contienen sustancias las cuales influyen en la accion de leucotrienos, para tratar rinitis/conjuntivitis.
NO20013966D0 (no) Kombinasjoner for behandling av sykdommer som involverer angiogenese
Khalid et al. Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo
EE200100136A (et) Atsetüülkoliini esteraasi inhibiitori ja psühhoosivastase toimeaine kasutamine ravimi valmistamiseks, mis on ette nähtud kognitsiooni- ja psühhoosihäirete raviks, ning neid aineid sisaldav farmatseutiline kompositsioon
DE69413829D1 (de) Antiglucocorticoidsteroide zur behandlung von angststörungen
BR9809022A (pt) Composições antiinflamatórias nasais tópicas
Bartlett et al. Rhinorrhea as a result of Alzheimer's disease treatment: a case report
DE60113664D1 (de) Zusammensetzung zur behandlung von herzinsuffizienz
DE69827295D1 (de) Kombination von einem den retinoinsäure metabolismus blockierenden arzneimittel und einem tocopherol
PE20011005A1 (es) Combinaciones de un inhibidor de fosfodiesterasa 4 y un antiinflamatorio esteroideo para el tratamiento de las enfermedades pulmonares
ES2159526T3 (es) Nuevos derivados de 4-(3-benzofuranil)piperidinilo y 4-(3-benzotienil)piperidinilo y composiciones farmaceuticas que los contienen.
KR970009812A (ko) 활성화 면역글로불린
MY130725A (en) Composition and method for treating allergic diseases
Kobayashi et al. Topical nasal sprays: treatment of allergic rhinitis.
영효김 et al. Crinical diagnostic guidelines for allergic rhinitis: medical treatment
PA8481701A1 (es) Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides